This announcement is a separate document:
日本エム・ディ・エム：人工股関節新製品Trivicta Hip Stemの米国食品医薬品局（FDA）薬事承認取得、及び米国販売に関するお知らせ
Japan Medical Dynamic Marketing: Notice regarding US Food and Drug Administration (FDA) regulatory approval and US sales of the new hip prosthetic product Trivicta Hip Stem
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.